IFITM3-NG Expression Plasmid

Designing Expression Plasmid Vectors in E. coli

The production of proteins is one of the main applications of genetic engineering in biotechnology. Even though standard cloning procedures are now routine and a large variety of host-vector systems for gene expression are available

Regulated Expression of Plasmid-Based Gene Therapies

or more (1 ,2 ). However, even during the first month, transgene expression levels are too variable and too low to provide consistent therapeutic levels of circulating proteins. Thus, most intramuscular plasmid-based gene therapy efforts have focused on indications that require short-term, low-level

Random Fragment Libraries Using Yeast Expression Plasmid

of chemically synthesized peptides (1 ,2 ), and/or the development of expression assays in prokaryotic or eukaryotic environments (3 ). The former approaches can be limited, since choice of sequences synthesized or of the chemistry involved